Showing results (271-280 of 308) with videos related to

Sort By:
Pageof 31
Iscience|October 10, 2022
Biparatopic nanobodies targeting the receptor binding domain efficiently neutralize SARS-CoV-2Phillip Pymm, Samuel J Redmond, Olan Dolezal, et al.
Medrxiv : the Preprint Server for Health Sciences|June 19, 2023
Comparative B cell and antibody responses induced by adenoviral vectored and mRNA vaccines against COVID-19Yi Liu, Stephany Sánchez-Ovando, Louise Carolan, et al.
Frontiers in Immunology|January 27, 2023
Corrigendum: Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2Bruce D Wines, Liriye Kurtovic, Halina M Trist, et al.
Clinical & Translational Immunology|March 8, 2021
Robust correlations across six SARS-CoV-2 serology assays detecting distinct antibody featuresLouise C Rowntree, Brendon Y Chua, Suellen Nicholson, et al.
JAMA Network Open|March 9, 2022
Comparison of Seroconversion in Children and Adults With Mild COVID-19Zheng Quan Toh, Jeremy Anderson, Nadia Mazarakis, et al.
Iscience|February 27, 2023
Incorporation of SARS-CoV-2 spike NTD to RBD protein vaccine improves immunity against viral variantsIsabelle Montgomerie, Thomas W Bird, Olga R Palmer, et al.
Frontiers in Immunology|August 15, 2022
Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2Bruce D Wines, Liriye Kurtovic, Halina M Trist, et al.
The Journal of Experimental Medicine|June 14, 2017
Recurrent rhinovirus infections in a child with inherited MDA5 deficiencyIan T Lamborn, Huie Jing, Yu Zhang, et al.
Annals of the New York Academy of Sciences|February 1, 2023
Respiratory viruses: New frontiers-a Keystone Symposia reportJennifer Cable, Jie Sun, In Su Cheon, et al.
Pageof 31